Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereof
US-2024101580-A1 · Mar 28, 2024 · US
US2018065994A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2018065994-A1 |
| Application number | US-201715801127-A |
| Country | US |
| Kind code | A1 |
| Filing date | Nov 1, 2017 |
| Priority date | Feb 1, 2013 |
| Publication date | Mar 8, 2018 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
This invention provides, among other things, novel compounds useful for treating protozoal infections, pharmaceutical compositions containing such compounds, as well as combinations of these compounds with at least one additional therapeutically effective agent.
Opening claim text (preview).
What is claimed is: 1 . A compound having a structure according to the following formulae: wherein R a is substituted or unsubstituted heteroaryl or substituted or unsubstituted heterocycloalkyl or a salt thereof. 2 . The compound of claim 1 , or a salt thereof, having a structure according to the following formulae: 3 . The compound of claim 1 , or a salt thereof, having a structure according to the following formulae: 4 . The compound of claim 1 , or a salt thereof, having a structure according to the following formulae: 5 . The compound of claim 1 , or a salt thereof, which is:
Related publications grouped by family.
Answers are generated from the same data shown on this page.